TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

Начало・Списък с акции・Genpact Ltd

Genpact Ltd

Затворен

СекторТехнологични

34.08 -0.18

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

33.12

Максимум

34.14

Ключови измерители
By Trading Economics
Приходи	-2.7M 143M
Продажби	28M 1.3B
P/E Средно за сектора	10.808 86.001
Дивидентна доходност	1.98
Марж на печалбата	10.846
Служители	146,500
EBITDA	-29M 201M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+33.57% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	1.98% 2.73%

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-1.9B 5.7B
Предишно отваряне	34.26
Предишно затваряне	34.08

Настроения в новините

By Acuity

50%

169 / 374 Класиране в Technology

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

4.95 / N/A Подкрепа & съпротива

Genpact Ltd Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

12.03.2026 г., 11:32 ч. UTC

Печалби

Italian Insurer Generali Posts Rise in Profit -- Update

12.03.2026 г., 11:20 ч. UTC

Печалби

Correction to Generali Flash Headlines

12.03.2026 г., 06:29 ч. UTC

Печалби

Italian Insurer Generali Posts Rise in Profit on Growth Across Segments

15.04.2026 г., 06:09 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Generali Could Consider Capital-Light M&A to Grow Franchise, Deputy CEO Says -- Market Talk

12.03.2026 г., 08:27 ч. UTC

Пазарно говорене

Generali's AI Disclosure Is Pleasing -- Market Talk

12.03.2026 г., 07:01 ч. UTC

Пазарно говорене

Печалби

Generali's Beat Should Get Positive Share Reaction -- Market Talk

12.03.2026 г., 06:04 ч. UTC

Печалби

Generali Backs 2027 View

12.03.2026 г., 06:04 ч. UTC

Печалби

Generali 2025 Life PVNBP EUR55.55B

12.03.2026 г., 06:04 ч. UTC

Печалби

Analysts Saw Generali 2025 Life PVNBP EUR56.03B

12.03.2026 г., 06:04 ч. UTC

Печалби

Analysts Saw Generali 2025 Life New Business Value EUR3.05B

12.03.2026 г., 06:04 ч. UTC

Печалби

Generali 2025 Life New Business Value EUR3.15B

12.03.2026 г., 06:04 ч. UTC

Печалби

Generali End-2025 Solvency Ratio 219%

12.03.2026 г., 06:04 ч. UTC

Печалби

Analysts Saw Generali End-2025 Solvency Ratio 212%

12.03.2026 г., 06:04 ч. UTC

Печалби

Analysts Saw Generali 2025 Undiscounted Combined Ratio 94.2%

12.03.2026 г., 06:04 ч. UTC

Печалби

Analysts Saw Generali 2025 Combined Ratio 92.5%

12.03.2026 г., 06:04 ч. UTC

Печалби

Generali 2025 Combined Ratio 92.6%

12.03.2026 г., 06:04 ч. UTC

Печалби

Generali 2025 Undiscounted Combined Ratio 94.3%

12.03.2026 г., 06:04 ч. UTC

Печалби

Analysts Saw Generali 2025 Dividend EUR1.59

12.03.2026 г., 06:04 ч. UTC

Печалби

Analysts Saw Generali 2025 Adj. Net Pft EUR4.31B

12.03.2026 г., 06:04 ч. UTC

Печалби

Generali Declares Dividend of EUR1.64

12.03.2026 г., 06:04 ч. UTC

Печалби

Generali 2025 Adj. Net Pft EUR4.315B

12.03.2026 г., 06:04 ч. UTC

Печалби

Generali Announces EUR500M Buyback for 2026

12.03.2026 г., 06:04 ч. UTC

Печалби

Generali 2025 Net Inflows EUR16B

12.03.2026 г., 06:04 ч. UTC

Печалби

Generali End-2025 Assets Under Management EUR899.93B

12.03.2026 г., 06:04 ч. UTC

Печалби

Generali 2025 Net Pft EUR4.17B

12.03.2026 г., 06:04 ч. UTC

Печалби

Analysts Saw Generali 2025 Oper Result EUR7.965B

12.03.2026 г., 06:04 ч. UTC

Печалби

Analysts Saw Generali 2025 Net Pft EUR4.225B

12.03.2026 г., 06:04 ч. UTC

Печалби

Generali 2025 Life Written Premiums EUR61.94B

12.03.2026 г., 06:04 ч. UTC

Печалби

Analysts Saw Generali 2025 Life Written Premiums EUR62.795B

12.03.2026 г., 06:04 ч. UTC

Печалби

Generali 2025 Gross Written Premiums EUR98.12B

Сравнение с други в отрасъла

Ценова промяна

Genpact Ltd Прогноза

Ценова цел

By TipRanks

33.57% нагоре

12-месечна прогноза

Среден 45.6 USD 33.57%

Висок 55 USD

Нисък 37 USD

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за Genpact Ltd през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

5 ratings

Купи

Задържане

Продай

Според 5 анализатори, дали борсови рейтинги на Genpact Ltd през последните 3 месеца.

Техническа оценка

By Trading Central

4.95 / N/AПодкрепа & съпротива

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Настроение

By Acuity

169 / 374 Класиране в Технологични

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Genpact Ltd

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims. The Consumer and Healthcare segment provides demand generation, sensing and planning, supply chain planning and management, pricing and trade promotion management, deduction recovery management, order management, and digital commerce; and end-to-end claim lifecycle management, from claims processing and adjudication to claims recovery and payment integrity, revenue cycle management, health equity analytics, and care services. The High Tech and Manufacturing segment offers industry-specific solutions for trust and safety, advertising sales support, customer and user experience, and customer care support; and direct and indirect procurement, logistics, field, aftermarket support, and engineering services. It also provides digital operation services; data-tech-Al services; finance and accounting services, such as accounts payable, invoice-to-cash, record to report, financial planning and analysis, and enterprise risk and compliance; CFO advisory services; supply chain, and sourcing and procurement services; sales and commercial, and marketing and experience services; and environmental, social and governance services. The company was founded in 1997 and is based in Hamilton, Bermuda.